George Elston Insider Profile
4 Followers
George Elston, CFO at EyePoint Pharmaceuticals, holds 122.47K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 18.50K shares in Celldex (Ticker: CLDX), holds 0.00 shares in Columbia Laboratories (Ticker: ~CBRX).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+19.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 09, 2020 - Sep 09, 2021
Return:+101.10%
The most profitable trade made by George Elston
George Elston's Trading History
EyePoint Pharmaceuticals
Aug 24, 2026
CFO
Uninformative Buy
―
$520.50K
Celldex
Jun 09, 2016
Director
Uninformative Buy
―
$724.83K
Columbia Laboratories
―
―
―
―
List of latest transactions for each holding click on a transaction to see George Elston's performance on stock
You May Also Like
George Elston insider profile FAQ
What is the percentage of profitable transactions made by George Elston?
The percentage of profitable transactions made by George Elston is 60%.
What is the average return per transaction made by George Elston?
The average return per transaction made by George Elston is 19.10%.
What stocks does George Elston hold?
George Elston holds: EYPT, CLDX, ~CBRX stocks.
What was George Elston’s latest transaction?
George Elston latest transaction was an Uninformative Buy of ―.
What was George Elston's most profitable transaction?
George Elston’s most profitable transaction was an Informative Buy of EYPT stock on September 9, 2020. The return on the trade was 101.10%.
What is George Elston's role in EyePoint Pharmaceuticals?
George Elston's role in EyePoint Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.